Project Details
Short title | Translational study for dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC |
---|---|
Status | Active |
Effective start/end date | 1/05/23 → 30/04/25 |
Funding
- IOX Therapeutics
Short title | Translational study for dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC |
---|---|
Status | Active |
Effective start/end date | 1/05/23 → 30/04/25 |